Instead of treating the acquisition as a simple portfolio diversification, Silo is positioning it as a strategic bridge between biotechnology […] The post Biotech Pioneer Expands Into Web3 With Altcoin Investment appeared first on Coindoo.Instead of treating the acquisition as a simple portfolio diversification, Silo is positioning it as a strategic bridge between biotechnology […] The post Biotech Pioneer Expands Into Web3 With Altcoin Investment appeared first on Coindoo.

Biotech Pioneer Expands Into Web3 With Altcoin Investment

2025/10/07 22:07

Instead of treating the acquisition as a simple portfolio diversification, Silo is positioning it as a strategic bridge between biotechnology and blockchain innovation. The company believes decentralized science (DeSci) could transform how breakthroughs are funded, shared, and rewarded, offering scientists a transparent alternative to traditional publishing models.

ResearchHub, founded by Coinbase CEO Brian Armstrong in 2019, allows researchers to share findings, peer-review work, and earn RSC tokens for their contributions. The project has drawn attention for its attempt to “open-source” the scientific process – removing paywalls and bureaucracy that often slow discovery.

Silo Pharma’s CEO, Eric Weisblum, said the investment represents more than a financial move: it’s a philosophical alignment with the next evolution of research infrastructure. “We see blockchain not only as a financial tool but as a mechanism for accelerating innovation in medicine and beyond,” he explained.

READ MORE:

Bitcoin’s Massive Rally Leaves Altcoins Behind, Says 10x Research

Following Silo’s announcement, ResearchCoin’s price climbed by around 4%, bringing its market capitalization to roughly $60 million. The token is currently listed on Coinbase, where trading volume surged as news of Silo’s involvement spread.

By stepping into the DeSci space, Silo Pharma becomes one of the first biopharma firms to directly support a Web3-driven research model. It signals a growing trend of traditional science companies embracing blockchain to democratize access to knowledge and potentially fast-track global collaboration in biomedical discovery.


The information provided in this article is for educational purposes only and does not constitute financial, investment, or trading advice. Coindoo.com does not endorse or recommend any specific investment strategy or cryptocurrency. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

The post Biotech Pioneer Expands Into Web3 With Altcoin Investment appeared first on Coindoo.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

This U.S. politician’s suspicious stock trade just returned over 200% in weeks

This U.S. politician’s suspicious stock trade just returned over 200% in weeks

The post This U.S. politician’s suspicious stock trade just returned over 200% in weeks appeared on BitcoinEthereumNews.com. United States Representative Cloe Fields has seen his stake in Opendoor Technologies (NASDAQ: OPEN) stock return over 200% in just a matter of weeks. According to congressional trade filings, the lawmaker purchased a stake in the online real estate company on July 21, 2025, investing between $1,001 and $15,000. At the time, the stock was trading around $2 and had been largely stagnant for months. Receive Signals on US Congress Members’ Stock Trades Stocks Stay up-to-date on the trading activity of US Congress members. The signal triggers based on updates from the House disclosure reports, notifying you of their latest stock transactions. Enable signal The trade has since paid off, with Opendoor surging to $10, a gain of nearly 220% in under two months. By comparison, the broader S&P 500 index rose less than 5% during the same period. OPEN one-week stock price chart. Source: Finbold Assuming he invested a minimum of $1,001, the purchase would now be worth about $3,200, while a $15,000 stake would have grown to nearly $48,000, generating profits of roughly $2,200 and $33,000, respectively. OPEN’s stock rally Notably, Opendoor’s rally has been fueled by major corporate shifts and market speculation. For instance, in August, the company named former Shopify COO Kaz Nejatian as CEO, while co-founders Keith Rabois and Eric Wu rejoined the board, moves seen as a return to the company’s early innovative spirit.  Outgoing CEO Carrie Wheeler’s resignation and sale of millions in stock reinforced the sense of a new chapter. Beyond leadership changes, Opendoor’s surge has taken on meme-stock characteristics. In this case, retail investors piled in as shares climbed, while short sellers scrambled to cover, pushing prices higher.  However, the stock is still not without challenges, where its iBuying model is untested at scale, margins are thin, and debt tied to…
Share
BitcoinEthereumNews2025/09/18 04:02